| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.525 | 0.003 | 0.525 | Factor Xa inhibitor | 0.469 0.003 DBMET02426 | ||
| 0.519 | 0.009 | 0.54 | Anticoagulant | 0.54 0.008 DBMET02426 | DBMET02426 | |
| 0.495 | 0.004 | 0.495 | Phosphodiesterase 4B inhibitor | 0.253 0.005 DBMET02426 | ||
| 0.409 | 0.006 | 0.409 | Tumour necrosis factor antagonist | 0.275 0.023 DBMET02426 | ||
| 0.419 | 0.024 | 0.419 | Tumour necrosis factor alpha release inhibitor | 0.377 0.031 DBMET02426 | ||
| 0.376 | 0.004 | 0.376 | Phosphodiesterase IV inhibitor | 0.186 0.015 DBMET02426 | ||
| 0.413 | 0.061 | 0.441 | Antiobesity | 0.441 0.052 DBMET02426 | DBMET02426 | |
| 0.333 | 0.004 | 0.333 | Factor X inhibitor | 0.331 0.004 DBMET02426 | ||
| 0.317 | 0.008 | 0.32 | Polo-like kinase-3 inhibitor | 0.32 0.008 DBMET02426 | DBMET02426 | |
| 0.291 | 0.004 | 0.291 | Phosphodiesterase 4C inhibitor | 0.23 0.005 DBMET02426 | ||
| 0.271 | 0.006 | 0.271 | Phosphodiesterase 4D inhibitor | 0.219 0.009 DBMET02426 | ||
| 0.3 | 0.048 | 0.319 | Vasodilator | 0.319 0.042 DBMET02426 | DBMET02426 | |
| 0.255 | 0.027 | 0.255 | MAP kinase kinase 3 inhibitor | 0.255 0.027 DBMET02426 | ||
| 0.25 | 0.037 | 0.25 | Focal adhesion kinase 2 inhibitor | 0.169 0.101 DBMET02426 | ||
| 0.212 | 0.016 | 0.212 | Bronchodilator | 0.21 0.017 DBMET02426 | ||
| 0.192 | 0.007 | 0.192 | Phosphodiesterase 4A inhibitor | 0.113 0.013 DBMET02426 | ||
| 0.309 | 0.15 | 0.395 | Calcium channel L-type activator | 0.395 0.085 DBMET02426 | DBMET02426 | |
| 0.203 | 0.05 | 0.235 | Thrombolytic | 0.235 0.038 DBMET02426 | DBMET02426 | |
| 0.151 | 0.004 | 0.151 | Bromodomain-containing protein 3 inhibitor | 0.144 0.004 DBMET02426 | ||
| 0.178 | 0.05 | 0.249 | Heat shock protein 90 antagonist | 0.249 0.021 DBMET02426 | DBMET02426 | |
| 0.128 | 0.007 | 0.129 | Polo-like kinase-2 inhibitor | 0.129 0.007 DBMET02426 | DBMET02426 | |
| 0.149 | 0.036 | 0.149 | GABA receptor agonist | 0.145 0.038 DBMET02426 | ||
| 0.115 | 0.006 | 0.115 | Cyclin A1 inhibitor | 0.108 0.007 DBMET02426 | ||
| 0.193 | 0.084 | 0.205 | Psychostimulant | 0.205 0.077 DBMET02426 | DBMET02426 | |
| 0.271 | 0.165 | 0.352 | Analgesic | 0.352 0.107 DBMET02426 | DBMET02426 | |
| 0.128 | 0.024 | 0.145 | Glutamate receptor agonist | 0.145 0.019 DBMET02426 | DBMET02426 | |
| 0.16 | 0.057 | 0.195 | Hemostatic | 0.195 0.035 DBMET02426 | DBMET02426 | |
| 0.136 | 0.032 | 0.154 | CDK2/cyclin A inhibitor | 0.154 0.025 DBMET02426 | DBMET02426 | |
| 0.266 | 0.17 | 0.266 | MAP kinase kinase 6 inhibitor | 0.261 0.176 DBMET02426 | ||
| 0.1 | 0.023 | 0.104 | Glutamate (mGluR) agonist | 0.104 0.022 DBMET02426 | DBMET02426 | |
| 0.224 | 0.15 | 0.274 | Antithrombotic | 0.274 0.108 DBMET02426 | DBMET02426 | |
| 0.107 | 0.039 | 0.107 | Polo-like kinase-1 inhibitor | 0.085 0.072 DBMET02426 | ||
| 0.155 | 0.089 | 0.179 | Neurotensin receptor agonist | 0.179 0.051 DBMET02426 | DBMET02426 | |
| 0.116 | 0.052 | 0.116 | Interleukin 2 antagonist | 0.115 0.054 DBMET02426 | ||
| 0.116 | 0.055 | 0.119 | Cyclin-dependent kinase 2 inhibitor | 0.119 0.053 DBMET02426 | DBMET02426 | |
| 0.164 | 0.103 | 0.164 | MAP kinase kinase 5 inhibitor | |||
| 0.117 | 0.061 | 0.12 | Sphingosine 1-phosphate receptor 2 agonist | 0.12 0.055 DBMET02426 | DBMET02426 | |
| 0.08 | 0.026 | 0.082 | Cannabinoid CB1 receptor antagonist | 0.082 0.025 DBMET02426 | DBMET02426 | |
| 0.083 | 0.03 | 0.088 | Cyclin A inhibitor | 0.088 0.027 DBMET02426 | DBMET02426 | |
| 0.128 | 0.075 | 0.128 | Phosphodiesterase inhibitor | |||
| 0.157 | 0.107 | 0.157 | Non-steroidal antiinflammatory agent | 0.147 0.119 DBMET02426 | ||
| 0.089 | 0.049 | 0.089 | GABA A receptor agonist | 0.079 0.065 DBMET02426 | ||
| 0.044 | 0.013 | 0.048 | AMPA receptor agonist | 0.048 0.01 DBMET02426 | DBMET02426 | |
| 0.155 | 0.124 | 0.155 | Anticonvulsant | 0.152 0.127 DBMET02426 | ||
| 0.075 | 0.044 | 0.075 | Cannabinoid receptor antagonist | 0.068 0.051 DBMET02426 | ||
| 0.068 | 0.04 | 0.077 | Cyclin A2 inhibitor | 0.077 0.034 DBMET02426 | DBMET02426 | |
| 0.104 | 0.078 | 0.104 | Acetylcholine release stimulant | |||
| 0.205 | 0.182 | 0.205 | Beta lactamase inhibitor | |||
| 0.056 | 0.037 | 0.056 | Bromodomain-containing protein 4 inhibitor | 0.049 0.047 DBMET02426 | ||
| 0.271 | 0.254 | 0.271 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.267 0.261 DBMET02426 | ||
| 0.061 | 0.045 | 0.097 | I kappa B kinase 2 inhibitor | 0.097 0.014 DBMET02426 | DBMET02426 | |
| 0.056 | 0.04 | 0.056 | Bruton tyrosine kinase inhibitor | 0.054 0.041 DBMET02426 | ||
| 0.077 | 0.066 | 0.111 | I kappa B kinase inhibitor | 0.111 0.031 DBMET02426 | DBMET02426 | |
| 0.07 | 0.061 | 0.07 | Glutamate (mGluR) antagonist | |||
| 0.078 | 0.068 | 0.099 | Antineoplastic alkaloid | 0.099 0.048 DBMET02426 | DBMET02426 | |
| 0.031 | 0.028 | 0.032 | Glutamate (mGluR group II) agonist | 0.032 0.027 DBMET02426 | DBMET02426 | |
| 0.028 | 0.027 | 0.028 | Glutamate (mGluR2) agonist | 0.028 0.027 DBMET02426 | ||
| 0.119 | 0.129 | 0.178 | Heat shock protein 90 alpha antagonist | 0.178 0.064 DBMET02426 | DBMET02426 | |
| 0.084 | 0.099 | 0.113 | 5 Hydroxytryptamine 3A agonist | 0.113 0.062 DBMET02426 | DBMET02426 | |
| 0.123 | 0.157 | 0.138 | Lipocortins synthesis antagonist | 0.138 0.125 DBMET02426 | DBMET02426 | |
| 0.145 | 0.194 | 0.188 | MAP-kinase-activated kinase 5 inhibitor | 0.188 0.119 DBMET02426 | DBMET02426 | |
| 0.097 | 0.168 | 0.123 | Cyclin-dependent kinase 8 inhibitor | 0.123 0.113 DBMET02426 | DBMET02426 | |
| 0.056 | 0.163 | 0.088 | MAP kinase kinase 7 inhibitor | 0.088 0.029 DBMET02426 | DBMET02426 | |
| 0.142 | 0.283 | 0.213 | Tyrosine 3 hydroxylase inhibitor | 0.213 0.114 DBMET02426 | DBMET02426 | |
| 0.138 | 0.281 | 0.205 | Insulysin inhibitor | 0.205 0.149 DBMET02426 | DBMET02426 | |
| 0.096 | 0.263 | 0.127 | MAP kinase kinase 4 inhibitor | 0.127 0.125 DBMET02426 | DBMET02426 | |
| 0.143 | 0.317 | 0.226 | Interleukin 2 agonist | 0.226 0.148 DBMET02426 | DBMET02426 | |
| 0.031 | 0.285 | 0.115 | Creatine kinase inhibitor | 0.115 0.045 DBMET02426 | DBMET02426 | |
| 0.025 | 0.416 | 0.092 | Estrogen receptor beta antagonist | 0.092 0.079 DBMET02426 | DBMET02426 | |
| 0.03 | 0.456 | 0.1 | Estrogen antagonist | 0.1 0.098 DBMET02426 | DBMET02426 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |